Evidence map›Paper›PMID 22087157›Full record

ArticleHepatitis monthly2011

Liver complications in celiac disease.

Mohammad Reza Zali, Mohammad Rostami Nejad, Kamran Rostami, Seyed Moayed Alavian

Open access · greenAbstract read
In one paragraph

Article in Hepatitis monthly, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Fatty liver and celiac disease: Why worry?World journal of hepatology · 2023
    Review
  6. Review
  7. Celiac Disease and Elevated Liver Enzymes: A Review.Journal of clinical and translational hepatology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Celiac disease: From pathophysiology to treatment.World journal of gastrointestinal pathophysiology · 2017
    Review
  14. Article
  15. Review
  16. Article
  17. Celiac disease and abnormal liver function test.International journal of preventive medicine · 2012
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohammad Reza ZaliResearch Center for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
Mohammad Rostami Nejad
Kamran Rostami
Seyed Moayed Alavian
Shahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Celiac disease (CD) is characterized by sensitivity to gluten, which is found in dietary wheat, barley, and rye. Many extra-intestinal manifestations have been described in association with CD. Liver disease and CD share widespread risk factors. Liver disorders such as autoimmune hepatitis, elevation of liver enzyme levels, primary biliary cirrhosis, nonspecific hepatitis, primary sclerosing cholangitis, and nonalcoholic fatty liver disease have been reported in patients with CD. In this review, we provide information regarding liver disorders that may be found in association with celiac disease and the effect of the treatment of CD on these disorders.

Indexed as

Celiac diseaseEpidemiologyLiver

Identifiers

PMID22087157
PMCPMC3212773
OpenAlexW1484937398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.